Neovasc Inc. (Nasdaq: NVCN) reported an 86% successful implantation rate for its Tiara transcatheter mitral valve sending the stock price soaring $1.00 to close at $2.42.
Neovasc provides Tiara implantation rate
December 06, 2016 at 16:22 PM EST
Neovasc provides Tiara implantation rateDecember 06, 2016 at 16:22 PM EST
Neovasc Inc. (Nasdaq: NVCN) reported an 86% successful implantation rate for its Tiara transcatheter mitral valve sending the stock price soaring $1.00 to close at $2.42. Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|